|
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
Savient Pharmaceuticals, Inc.(NASDAQ:SVNT) announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic PEGylated...
|
|
|
Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
According to the American Cancer Society [ACS], non-Hodgkin lymphoma [also known as non-Hodgkins lymphoma, NHL, or sometimes just lymphoma] is a cancer that starts in cells of the lymph system, which is part of the bodys immune system.NHL...
|
|
|
Masitinib May Be Effective Against Refractory Rheumatoid Arthritis
_ Masitinib May Be Effective Against Refractory Rheumatoid Arthritis.
|
|
|
Masitinib May Be Effective Against Refractory Rheumatoid Arthritis
_ Masitinib May Be Effective Against Refractory Rheumatoid Arthritis.
|
|
|
Advisory Panel Recommends Approval of Pegloticase for the Treatment of Refractory Chronic Gout
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.(Nasdaq: SVNT) announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of...
|
|
|
Refractory Anaphylactic Cardiac Arrest After Succinylcholine Administration
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Anesthesia & Analgesia, 06/23/09 Print Save in My Library Free Abstract Baumann A et al.- Refractory shock from anaphylaxis can occur after...
|
|
|
Certolizumab Pegol Add-On Effective in Refractory RA: Study
_ Certolizumab Pegol Add-On Effective in Refractory RA: Study.
|
|
|
Certolizumab Pegol Add-On Effective in Refractory RA: Study
_ Certolizumab Pegol Add-On Effective in Refractory RA: Study.
|
|
|
Experience With Use of Extracorporeal Life Support for Severe Refractory Status Asthmaticus in Children
_ Experience With Use of Extracorporeal Life Support for Severe Refractory Status Asthmaticus in Children.
|
|
|
Molecular Profiling Shown to Pick Improved Treatments for Refractory Cancers
DENVER-A prospective study of molecular profiling has shown that it is possible to measure molecular targets in patients' tumors, and that when the treatments are selected by molecular profiling, patients can have longer progression-free...
|
|
|
Levofloxacin Combination Effective Against Refractory H. Pylori
_ Levofloxacin Combination Effective Against Refractory H.Pylori.
|
|
|
Levofloxacin Combination Effective Against Refractory H. Pylori
_ Levofloxacin Combination Effective Against Refractory H.Pylori.
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
t 8:30 a.m.Eastern Time EAST BRUNSWICK, N.J., June 16 (HSMN NewsFeed) -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA)...
|
|
|
U.S. FDA Panel Urges Approval of Savient Pharmaceuticals, Inc. (SVNT) Gout Drug; PDUFA Action Date is August 1
t 8:30 a.m.Eastern Time EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
t 8:30 a.m.Eastern Time EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food And Drug Administration Approval For KRYSTEXXA
Savient Pharmaceuticals, Inc.(Nasdaq: SVNT) announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic PEGylated...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
Savient to Host Conference Call and Webcast on Wednesday, June 17 at 8:30 a.m.Eastern Time EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. announced today that the Arthritis Advisory Committee...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
Savient Pharmaceuticals, Inc.announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic PEGylated uricase...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
t 8:30 a.m.Eastern Time EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.(Nasdaq: SVNT) announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.(Nasdaq: SVNT) announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.(Nasdaq: SVNT) announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of...
|
|
|
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA
EAST BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.(Nasdaq: SVNT) announced today that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of...
|
